Oncoquest-Ovarian cancer

N/A

Report date: 2025/01/26 16:39:08

Base Information

Drug NameOncoquest-Ovarian cancer
Drug Alias NameIL-2/TMA-S (Xeme Biopharma)
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXeme Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesXeme Biopharma Inc
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A